Mangoceuticals announces that it has officially launched its direct-to-clinics sales division offering doctors and medical practitioners the ability to prescribe MangoRx products to their patients directly from their offices, clinics and brick and mortar locations. The Company also reports that it has successfully onboarded its first medical health and wellness clinic based in Dallas, TX last week. Jacob Cohen, MangoRx’s Co-Founder and CEO noted, “our initial research has shown that some of these providers prescribe as many as 6,000 to 7,000 ED prescriptions per year from within their offices or clinics. This amount, compounded with the opportunity for them to also prescribe ‘PRIME’, by MangoRx, powered by Kyzatrex, presents an exponential growth opportunity especially given PRIME’s $199 monthly subscription rate. We are confident that this new initiative will fuel our revenue growth and have a further impact on making MangoRx a household name.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MGRX:
- Mangoceuticals offers one year supply of Mango ED to San Francisco players
- Mangoceuticals to offer one year supply of Mango ED to Big Game losing team
- MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS
- Mangoceuticals accepting preorders for PRIME
- MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product